We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.

Be Part of the Asia Pacific MedTech Forum 2024

Home » Our Work » IVD

In Vitro Diagnostics

Introduction

Working Group Objectives & Projects

Resources

OUR LEADERSHIP TEAM

In Vitro Diagnostics

The IVD Working Group is a specialised group that focuses on issues related to in-vitro diagnostics (IVD) across key areas such as regulatory affairs, market access, and government affairs and policy. The working group is composed of representatives from various IVD member companies and experts in the field who collaborate to tackle industry challenges, advocate for supportive policies, and ensure that IVD products are both accessible and meet rigorous regulatory standards.

Objectives of the In Vitro Diagnostics Working Group:

Current Projects:

Strengthen the Role of Diagnostics in Public Health
Collaborate with local governments to advance the implementation of World Health Assembly Resolution on Diagnostics in APAC.
Facilitate a Standardised and Clear Regulatory Framework For IVD
Develop a landscape to highlight both the alignments and the divergent practices on LDTs regulations across the globe.
Unlock the Value of Next Generation Sequencing
Advancing patient access to NGS technologies for cancer care in the region.

Access Resources

Market Access

Advancing Patient Access to Next-Generation Sequencing for Cancer in APAC: Key considerations and a value assessment framework

Government Affairs & Policy

Value of In-vitro diagnostics in APAC: Value Assessment Framework with applications for Cardiovascular Diseases

Blog

Next Generation Sequencing: How It Works, Techniques, Steps, Advantages and Technologies

Government Affairs & Policy

Strengthening Healthcare Systems Through the Critical Role of Diagnostics

OUR LEADERSHIP TEAM

Lance Little

Head of Region
Roche Diagnostics Asia Pacific

Board Sponsor

Anirudh Sen

Head, Market Access
Lead, IVD

Secretariat Lead

Who We Are

APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.

Be Part of the Asia Pacific MedTech Forum 2024

APACMed

In Vitro Diagnostics

In Vitro Diagnostics

Company Representation

Access Resources

Advancing Patient Access to Next-Generation Sequencing for Cancer in APAC: Key considerations and a value assessment framework

Value of In-vitro diagnostics in APAC: Value Assessment Framework with applications for Cardiovascular Diseases

Next Generation Sequencing: How It Works, Techniques, Steps, Advantages and Technologies